Compile Data Set for Download or QSAR
Report error Found 47 Enz. Inhib. hit(s) with all data for entry = 6099
Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  0.280nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  0.5nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  0.700nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  1nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  1.60nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  2nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  2.30nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  2.5nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  5nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  5.90nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  6nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  7.10nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  9nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  9.60nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  10nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  10nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  11nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50395582(CHEMBL2165133 | UNC10000004 | US9156822, 25)
Affinity DataEC50:  12nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  13nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  14nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  15nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50395583(CHEMBL2165132 | UNC10099973 | US9156822, 31)
Affinity DataEC50:  16nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50395581(CHEMBL2165134 | UNC10000010 | US9156822, 28)
Affinity DataEC50:  18nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  19nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  20nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  26nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  28nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  31nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM185693(UNC10099988 | US9156822, 34)
Affinity DataEC50:  36nMMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetAlpha-1A adrenergic receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi:  60nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  63nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  100nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi:  112nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  130nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi:  190nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2A(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  202nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50130293(7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}...)
Affinity DataKi:  240nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetD(2) dopamine receptor(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  400nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetHistone H1.0(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  780nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001884(8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50001885(3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin...)
Affinity DataKi:  1.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50048803(5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-et...)
Affinity DataKi: >1.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM50095890(2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-...)
Affinity DataKi:  2.00E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

Target5-hydroxytryptamine receptor 2C(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM21398(4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1...)
Affinity DataKi:  3.95E+3nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent

TargetSodium-dependent serotonin transporter(Human)
Intra-Cellular Therapies

US Patent
LigandPNGBDBM35254(CHEMBL715 | 2-methyl-4-(4-methylpiperazin-1-yl)-10...)
Affinity DataKi: >1.00E+4nMAssay Description:Binding assay using 5-HT2A, Dopamine D2, SERT, αA1, 5-HT2C and H1 Receptors.More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/5/2014
Entry Details
US Patent